2021
DOI: 10.2147/itt.s240891
|View full text |Cite
|
Sign up to set email alerts
|

The Role of IL-17 Cytokines in Psoriasis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
29
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 45 publications
(29 citation statements)
references
References 74 publications
0
29
0
Order By: Relevance
“…Therefore, a greater understanding of how Th17 cells and IL-17 are involved in the pathogenesis of SLE will help determine whether IL-17 is a promising therapeutic target. Novel biologic agent targeting directed toward IL-17 (secukinumab, ixekizumab, bimekizumab) and IL-17R (brodalumab) are approved for the treatment of psoriasis in the United States (38). A phase III, randomized, double-blind, placebo-controlled, 2-year study to evaluate the efficacy and safety of secukinumab in combination with standard therapy in patients with SLE with active nephritis (NCT04181762) is currently ongoing.…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, a greater understanding of how Th17 cells and IL-17 are involved in the pathogenesis of SLE will help determine whether IL-17 is a promising therapeutic target. Novel biologic agent targeting directed toward IL-17 (secukinumab, ixekizumab, bimekizumab) and IL-17R (brodalumab) are approved for the treatment of psoriasis in the United States (38). A phase III, randomized, double-blind, placebo-controlled, 2-year study to evaluate the efficacy and safety of secukinumab in combination with standard therapy in patients with SLE with active nephritis (NCT04181762) is currently ongoing.…”
Section: Discussionmentioning
confidence: 99%
“…Finally, disease-specific cellular and molecular events in psoriasis are directly linked to the TNF–IL-23–Th17 inflammatory pathway [ 41 ]. The IL-17 cytokine family consists of six members (IL-17A, IL-17B, IL-17C, IL-17D, IL-17E and IL17F), with IL-17A and IL-17F being primarily associated with clinically relevant signaling in psoriasis, acting through the same receptor, but with varying potencies [ 42 ]. The biological effects of IL-17A are greater than those exerted by IL-17F, while the IL-17A/IL-17F heterodimer has an intermediate effect.…”
Section: Immunopathogenesis Of Psoriasis Vulgarismentioning
confidence: 99%
“…PS is strongly associated with dysfunctional helper T cells (Th1, Th17, Th22, and Treg) and is characterized by sharply delineated scaly erythematous plaques. In plaque PS, the intricate inflammatory cascade mediated by the IL-23/IL-17 pathway acts on keratinocytes, endothelial cells, and immune cells, thereby stimulating epidermal hyperplasia and the pro-inflammatory feed-forward circuit [ 71 ]. In addition, the function of Tregs, which play a fundamental role in immune homeostasis by suppressing immune responses, appears to be impaired in PS, which leads to an altered ratio of Th17 to Treg and exacerbation of the disease [ 72 ].…”
Section: Autophagy In Inflammatory Skin Diseasesmentioning
confidence: 99%